SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-23-032462
Filing Date
2023-11-17
Accepted
2023-11-17 16:03:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 rvph20231116_424b5.htm 424B5 535509
2 rvph20231116_424b5img001.jpg GRAPHIC 4096
3 rvph20231116_424b5img002.jpg GRAPHIC 5242
4 rvph20231116_424b5img003.jpg GRAPHIC 7981
  Complete submission text file 0001437749-23-032462.txt   560924
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262348 | Film No.: 231418547
SIC: 2834 Pharmaceutical Preparations